Literature DB >> 10491447

Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun.

R G Stirling, K F Chung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10491447      PMCID： PMC1745369          DOI： 10.1136/thx.54.10.865

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  7 in total

Review 1.  Leukotriene receptor antagonist therapy.

Authors:  O J Dempsey
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

Review 2.  Wegener's granulomatosis and the Churg-Strauss syndrome.

Authors:  J L Faul; W G Kuschner
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

Review 3.  Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

Authors:  Richard B R Muijsers; Stuart Noble
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

5.  Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal.

Authors:  S Hayashi; S Furuya; H Imamura
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

6.  Churg-Strauss syndrome (CSS) in a patient receiving pranlukast.

Authors:  Shigeto Kobayashi; Shyugo Ishizuka; Naoto Tamura; Makiyo Takaya; Kazuhiko Kaneda; Hiroshi Hashimoto
Journal:  Clin Rheumatol       Date:  2003-11-04       Impact factor: 2.980

Review 7.  Pranlukast: a review of its use in the management of asthma.

Authors:  Susan J Keam; Katherine A Lyseng-Williamson; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.